FUJIFILM (China) Investment Co., Ltd.
Since its establishment in 1934, Fuji Film Co., Ltd. has been moving forward with firm steps and has developed to become the world's largest comprehensive image, information, file processing products and services. and suppliers. Fuji Film (China) Investment Co., Ltd. was established on April 12, 2001. It is a wholly-owned company established by Fuji Film Co., Ltd. in Shanghai, China to expand its business in mainland China. In 2002, it became one of the China headquarters recognized by Shanghai. , was recognized as a national regional headquarters by the Ministry of Commerce in 2013. The main business includes digital cameras, imaging, medical care, printing, high-performance materials, optical components, etc.
FUJIFILM (China) Investment Co., Ltd.
Since its establishment in 1934, Fuji Film Co., Ltd. has been moving forward with firm steps and has developed to become the world's largest comprehensive image, information, file processing products and services. and suppliers. Fuji Film (China) Investment Co., Ltd. was established on April 12, 2001. It is a wholly-owned company established by Fuji Film Co., Ltd. in Shanghai, China to expand its business in mainland China. In 2002, it became one of the China headquarters recognized by Shanghai. , was recognized as a national regional headquarters by the Ministry of Commerce in 2013. The main business includes digital cameras, imaging, medical care, printing, high-performance materials, optical components, etc.
Olympus (China) Co., Ltd.
In 1949, Olympus Optical Industry was commissioned by doctors from the Affiliated Hospital of the University of Tokyo in Japan to develop a "camera that can photograph the inside of a patient's stomach", which was later the "stomach camera". With Olympus' technical accumulation in the field of optical, a series of repeated experiments, including the production of micro lenses, the discussion of strong light sources, the exploration of main soft pipes, the selection of appropriate films, and the research of waterproofing measures, have been carried out one after another. In 1950, after all the difficulties that were difficult to describe, a stomach camera was created. It is generally recognized by the medical community that endoscopy is the "gold standard" for gastrointestinal cancer detection. Modern endoscopic technology is different now, and the pain caused by endoscopic testing to patients has been greatly reduced. Olympus' capsule endoscopy for small intestine examination has also been put into clinical use, achieving simple and painless internal diagnosis of the small intestine.
Olympus (China) Co., Ltd.
In 1949, Olympus Optical Industry was commissioned by doctors from the Affiliated Hospital of the University of Tokyo in Japan to develop a "camera that can photograph the inside of a patient's stomach", which was later the "stomach camera". With Olympus' technical accumulation in the field of optical, a series of repeated experiments, including the production of micro lenses, the discussion of strong light sources, the exploration of main soft pipes, the selection of appropriate films, and the research of waterproofing measures, have been carried out one after another. In 1950, after all the difficulties that were difficult to describe, a stomach camera was created. It is generally recognized by the medical community that endoscopy is the "gold standard" for gastrointestinal cancer detection. Modern endoscopic technology is different now, and the pain caused by endoscopic testing to patients has been greatly reduced. Olympus' capsule endoscopy for small intestine examination has also been put into clinical use, achieving simple and painless internal diagnosis of the small intestine.
Stryker (Beijing) Medical Devices Co., Ltd.
As one of the world's cutting-edge medical technology companies, Stryker works sincerely with customers and is committed to improving healthcare. The company provides a range of innovative products and services including plastic surgery, medical and surgical equipment, neurosurgery and spine-related products to help improve the treatment experience of patients and medical institutions. Dr. Homer Stryker, an orthopedic physician in Kalamazoo, Michigan, invented a series of new products after discovering that some medical products cannot meet the needs of patients. There is growing concern and interest in these new medical products, and Dr. Stryker founded The Orthopaedic Frame Company in 1941, specializing in the production of these innovative medical products. In 1942, the company began to build wedge-shaped turnover beds, which allow caregivers to turn over patients with severe back injuries while keeping their spine fixed; In 1946, Stryker founded The Orthopaedic Frame Company; In 1979, the company issued its shares for the first time, bringing more attention to the company; in the same year, Stryker acquired Osteonics Corp. and entered the orthopedic implant market; In 1981, the company's acquisition of SynOptics provided an opportunity to expand into its endoscope business; In 1992, the acquisition of Dimso, SA opened up business opportunities in the field of spinal fixation; In 1996, the acquisition of Osteo SA provided an opportunity to enter the bone trauma market; In 1997, 18 years after the company was listed on the Nasdaq, the company was listed on the New York Stock Exchange; In 1998, the company acquired Howmedica, a major player in the orthopedic market, and doubled its size in the coming year. In 2009, the company acquired Ascent Healthcare Solutions, Inc., a leading market leader in the U.S. medical device reprocessing and remanufacturing market; In 2011, the company acquired Boston Scientific's neurovascular division, greatly expanding the brand's neurotechnology business; In 2013, the company acquired Trauson Holdings Company Limited to expand into high-value market segments in emerging markets. In the same year, the company's acquisition of MAKO Surgical Corp provided an opportunity to further promote the development of robotic arm-assisted surgery in orthopedics.
Stryker (Beijing) Medical Devices Co., Ltd.
As one of the world's cutting-edge medical technology companies, Stryker works sincerely with customers and is committed to improving healthcare. The company provides a range of innovative products and services including plastic surgery, medical and surgical equipment, neurosurgery and spine-related products to help improve the treatment experience of patients and medical institutions. Dr. Homer Stryker, an orthopedic physician in Kalamazoo, Michigan, invented a series of new products after discovering that some medical products cannot meet the needs of patients. There is growing concern and interest in these new medical products, and Dr. Stryker founded The Orthopaedic Frame Company in 1941, specializing in the production of these innovative medical products. In 1942, the company began to build wedge-shaped turnover beds, which allow caregivers to turn over patients with severe back injuries while keeping their spine fixed; In 1946, Stryker founded The Orthopaedic Frame Company; In 1979, the company issued its shares for the first time, bringing more attention to the company; in the same year, Stryker acquired Osteonics Corp. and entered the orthopedic implant market; In 1981, the company's acquisition of SynOptics provided an opportunity to expand into its endoscope business; In 1992, the acquisition of Dimso, SA opened up business opportunities in the field of spinal fixation; In 1996, the acquisition of Osteo SA provided an opportunity to enter the bone trauma market; In 1997, 18 years after the company was listed on the Nasdaq, the company was listed on the New York Stock Exchange; In 1998, the company acquired Howmedica, a major player in the orthopedic market, and doubled its size in the coming year. In 2009, the company acquired Ascent Healthcare Solutions, Inc., a leading market leader in the U.S. medical device reprocessing and remanufacturing market; In 2011, the company acquired Boston Scientific's neurovascular division, greatly expanding the brand's neurotechnology business; In 2013, the company acquired Trauson Holdings Company Limited to expand into high-value market segments in emerging markets. In the same year, the company's acquisition of MAKO Surgical Corp provided an opportunity to further promote the development of robotic arm-assisted surgery in orthopedics.
Pocos International Medical Trading (Shanghai) Co., Ltd.
Boston Science continues to develop breakthrough medical technologies and products, contributing to the progress of multiple medical fields. Committed to reducing patient trauma, reducing medical costs, and effectively improving the quality of life. Boston Science currently owns more than 13,000 life-improving products, and the company invests more than $1 billion in research and development every year. Boston Science is committed to improving people's lives and improving the health quality of patients around the world through innovative medical solutions. Innovating for life is the mission of Boston Science and a commitment to patients, physicians and medical systems around the world. About 30 million patients benefit from Boston’s scientific innovative medical solutions each year.
Pocos International Medical Trading (Shanghai) Co., Ltd.
Boston Science continues to develop breakthrough medical technologies and products, contributing to the progress of multiple medical fields. Committed to reducing patient trauma, reducing medical costs, and effectively improving the quality of life. Boston Science currently owns more than 13,000 life-improving products, and the company invests more than $1 billion in research and development every year. Boston Science is committed to improving people's lives and improving the health quality of patients around the world through innovative medical solutions. Innovating for life is the mission of Boston Science and a commitment to patients, physicians and medical systems around the world. About 30 million patients benefit from Boston’s scientific innovative medical solutions each year.
Karl Storz Endoscopy (Shanghai) Co., Ltd.
Since 1945, Carl Stots has continuously promoted the advancement of medical technology through innovation. From a unknown two-person company in Black Forest, Germany, it has gradually grown into a global leader in the endoscope industry. The family business that has inherited three generations now has 8,800 employees worldwide, with the number of employees at the headquarters alone reaching 3,000. Carl Stots has more than 15,000 human and veterinary medical products for early diagnosis of cancer, minimally invasive surgery, and save patients' lives. Human health and enthusiasm for product innovation are the driving force behind Foshan's continuous progress. The company's products have forward-looking design, excellent craftsmanship and excellent clinical results.
Karl Storz Endoscopy (Shanghai) Co., Ltd.
Since 1945, Carl Stots has continuously promoted the advancement of medical technology through innovation. From a unknown two-person company in Black Forest, Germany, it has gradually grown into a global leader in the endoscope industry. The family business that has inherited three generations now has 8,800 employees worldwide, with the number of employees at the headquarters alone reaching 3,000. Carl Stots has more than 15,000 human and veterinary medical products for early diagnosis of cancer, minimally invasive surgery, and save patients' lives. Human health and enthusiasm for product innovation are the driving force behind Foshan's continuous progress. The company's products have forward-looking design, excellent craftsmanship and excellent clinical results.
Medical Electronics Co., Ltd.
Shenzhen Kaili Biomedical Technology Co., Ltd. (stock code: 300633) is a global advanced technology company dedicated to the independent research and development and manufacturing of medical equipment, covering ultrasound medical imaging, endoscopic diagnosis and treatment, minimally invasive surgery and cardiovascular intervention. In the field, it provides professional and specialized overall solutions for medical institutions in more than 170 countries and regions around the world. Kaili Medical is determined to become a technological force to protect global health and create more possibilities for life.
Medical Electronics Co., Ltd.
Shenzhen Kaili Biomedical Technology Co., Ltd. (stock code: 300633) is a global advanced technology company dedicated to the independent research and development and manufacturing of medical equipment, covering ultrasound medical imaging, endoscopic diagnosis and treatment, minimally invasive surgery and cardiovascular intervention. In the field, it provides professional and specialized overall solutions for medical institutions in more than 170 countries and regions around the world. Kaili Medical is determined to become a technological force to protect global health and create more possibilities for life.
Suzhou Guoke Meirunda Medical Technology Co., Ltd.
Suzhou Guoke Meirunda Medical Technology Co., Ltd. was established in 2014. It is a high-tech medical device enterprise focusing on the research and development, production and sales of smart endoscopic camera systems. Meirunda is the earliest manufacturer in China to obtain the registration certificate for fluorescent camera system of the Drug Administration. Currently, the company's main products include ultra-high-definition fluorescent camera system/cold light source, ultra-high-definition white light camera system/cold light source, 4K fluorescent camera system, 4K White light camera system, fluorescent 3D image processing system, 5K fluorescent imaging system, intelligent pneumatic abdomen instrument, binocular 3D fluorescent imaging system and other fields. The company has currently obtained 4 US patents and 28 domestic patents, and has also obtained ISO13485 certification and CE certification of products. In the future, in the field of smart imaging, we will continue to adhere to thinking and innovation as the core, and guided by the needs of patients and doctors, and contribute our own efforts to the continuous scientific and technological innovation in the field of endoscopic fluorescence imaging systems.
Suzhou Guoke Meirunda Medical Technology Co., Ltd.
Suzhou Guoke Meirunda Medical Technology Co., Ltd. was established in 2014. It is a high-tech medical device enterprise focusing on the research and development, production and sales of smart endoscopic camera systems. Meirunda is the earliest manufacturer in China to obtain the registration certificate for fluorescent camera system of the Drug Administration. Currently, the company's main products include ultra-high-definition fluorescent camera system/cold light source, ultra-high-definition white light camera system/cold light source, 4K fluorescent camera system, 4K White light camera system, fluorescent 3D image processing system, 5K fluorescent imaging system, intelligent pneumatic abdomen instrument, binocular 3D fluorescent imaging system and other fields. The company has currently obtained 4 US patents and 28 domestic patents, and has also obtained ISO13485 certification and CE certification of products. In the future, in the field of smart imaging, we will continue to adhere to thinking and innovation as the core, and guided by the needs of patients and doctors, and contribute our own efforts to the continuous scientific and technological innovation in the field of endoscopic fluorescence imaging systems.
AnHui Medical Technology (Wuhan) Co., Ltd.
Anhan Technology was founded in 2009 and is a high-tech enterprise focusing on the research, development, production and operation of innovative medical devices in the field of digestive tract health. The company focuses on international cutting-edge medical technology innovation and is the pioneer and pioneer of magnetron capsule gastroscopy technology. It is committed to promoting comfortable and precise premature screening of digestive tract diseases, and opens up an intelligent health management platform for the prevention of digestive tract diseases. The closed loop of screening, diagnosis, treatment and health helps a healthy China. Anhan Technology's gastrointestinal disease screening products ( Anhan "magnet-controlled capsule gastroscopy system" ) and constipation treatment products (Vibra Bot™ "digestive tract vibration capsule system") provide new ideas for world medical technology. Among them, the "magnetically controlled capsule gastroscopy system" has achieved comfortable stomach accuracy examination of "no intubation and gastroscopy", and obtained the registration certificate of the third category of medical device of the "magnetically controlled capsule gastroscopy system" issued by the State Food and Drug Administration and the EU CE certification and passed the US De Novo FDA innovative medical device registration. At present, this product has been clinically used in nearly 1,000 medical institutions in 31 provinces, cities and autonomous regions across the country, and has been sold to overseas markets. Clinical studies have shown that the accuracy of Anhan's "magnet-controlled capsule gastroscopy system" for gastric diseases is highly consistent with that of electronic gastroscopy. Its comfortable examination method effectively solves the pain point of people's gastroscopy "dare not to check, are unwilling to check, and cannot check" and is especially suitable for asymptomatic people to have gastric physical examinations and improves the detection rate of early gastric cancer in China. With the massive growth of clinical data, the integration of AI technology, and the development of interdisciplinary research, Anhan's "Magnet-controlled capsule gastroscopy system" application department has been continuously expanded, covering gastrointestinal department, physical examination department, cardiology, geriatric department, pediatric department, and emergency diagnosis. and other disciplines. Among them, clinical research that penetrates the Department of Cardiology and Gastroenterology has created a new era of cross-disciplinary cross-section and precise prevention and control of digestive tract bleeding after intracardiac PCl surgery. As an innovative medical device product used in constipation treatment, Anhan's "Gastronomical Vibration Capsule System" (VibraBot™), has ushered in a new era of pure physical treatment of constipation. This product is based on the theory of physical nerve stimulation, promotes intestinal peristalsis through massage, solves constipation problems, and has obtained the innovative medical device registration certificate (class III medical devices) issued by the State Food and Drug Administration. Currently, no similar products are on the market at home and abroad. Technological innovation is the foundation of Anhan. At present, Anhan Technology has more than 300 authorized patents at home and abroad, of which invention patents account for as much as 40%, and its R&D strength demonstrates the true nature of science and technology innovation. As a model of integration of medicine and engineering, Anhan products have always been a hot topic in clinical research. A large number of landmark evidence-based research results have been published in international academic journals. Relying on artificial intelligence and 5G technology, Anhan Technology has innovatively launched the "magnet-controlled capsule gastroscopy mobile examination vehicle", realizing mobile examination of gastroscopy and online remote consultation, effectively allocating medical resources and promoting the "center of gravity to the screening of gastrointestinal tumors. ” and “shift forward”. Combined with Internet + medical care, Anhan Technology's closed-loop full-gastrointestinal health management platform for "preventing serious diseases, managing chronic diseases, and promoting health" has taken shape. Technology makes life healthier. In the future, Anhan Technology will continue to take protecting the health of the digestive tract of the people as its mission, continuously enrich the product structure in the field of digestive tract health, promote the high-quality development of domestic medical devices, and create an intelligent full-gastrointestinal health management platform to better serve health. Life, protect a healthy China!
AnHui Medical Technology (Wuhan) Co., Ltd.
Anhan Technology was founded in 2009 and is a high-tech enterprise focusing on the research, development, production and operation of innovative medical devices in the field of digestive tract health. The company focuses on international cutting-edge medical technology innovation and is the pioneer and pioneer of magnetron capsule gastroscopy technology. It is committed to promoting comfortable and precise premature screening of digestive tract diseases, and opens up an intelligent health management platform for the prevention of digestive tract diseases. The closed loop of screening, diagnosis, treatment and health helps a healthy China. Anhan Technology's gastrointestinal disease screening products ( Anhan "magnet-controlled capsule gastroscopy system" ) and constipation treatment products (Vibra Bot™ "digestive tract vibration capsule system") provide new ideas for world medical technology. Among them, the "magnetically controlled capsule gastroscopy system" has achieved comfortable stomach accuracy examination of "no intubation and gastroscopy", and obtained the registration certificate of the third category of medical device of the "magnetically controlled capsule gastroscopy system" issued by the State Food and Drug Administration and the EU CE certification and passed the US De Novo FDA innovative medical device registration. At present, this product has been clinically used in nearly 1,000 medical institutions in 31 provinces, cities and autonomous regions across the country, and has been sold to overseas markets. Clinical studies have shown that the accuracy of Anhan's "magnet-controlled capsule gastroscopy system" for gastric diseases is highly consistent with that of electronic gastroscopy. Its comfortable examination method effectively solves the pain point of people's gastroscopy "dare not to check, are unwilling to check, and cannot check" and is especially suitable for asymptomatic people to have gastric physical examinations and improves the detection rate of early gastric cancer in China. With the massive growth of clinical data, the integration of AI technology, and the development of interdisciplinary research, Anhan's "Magnet-controlled capsule gastroscopy system" application department has been continuously expanded, covering gastrointestinal department, physical examination department, cardiology, geriatric department, pediatric department, and emergency diagnosis. and other disciplines. Among them, clinical research that penetrates the Department of Cardiology and Gastroenterology has created a new era of cross-disciplinary cross-section and precise prevention and control of digestive tract bleeding after intracardiac PCl surgery. As an innovative medical device product used in constipation treatment, Anhan's "Gastronomical Vibration Capsule System" (VibraBot™), has ushered in a new era of pure physical treatment of constipation. This product is based on the theory of physical nerve stimulation, promotes intestinal peristalsis through massage, solves constipation problems, and has obtained the innovative medical device registration certificate (class III medical devices) issued by the State Food and Drug Administration. Currently, no similar products are on the market at home and abroad. Technological innovation is the foundation of Anhan. At present, Anhan Technology has more than 300 authorized patents at home and abroad, of which invention patents account for as much as 40%, and its R&D strength demonstrates the true nature of science and technology innovation. As a model of integration of medicine and engineering, Anhan products have always been a hot topic in clinical research. A large number of landmark evidence-based research results have been published in international academic journals. Relying on artificial intelligence and 5G technology, Anhan Technology has innovatively launched the "magnet-controlled capsule gastroscopy mobile examination vehicle", realizing mobile examination of gastroscopy and online remote consultation, effectively allocating medical resources and promoting the "center of gravity to the screening of gastrointestinal tumors. ” and “shift forward”. Combined with Internet + medical care, Anhan Technology's closed-loop full-gastrointestinal health management platform for "preventing serious diseases, managing chronic diseases, and promoting health" has taken shape. Technology makes life healthier. In the future, Anhan Technology will continue to take protecting the health of the digestive tract of the people as its mission, continuously enrich the product structure in the field of digestive tract health, promote the high-quality development of domestic medical devices, and create an intelligent full-gastrointestinal health management platform to better serve health. Life, protect a healthy China!
Nanwei Medical Technology Co., Ltd.
Nanwei Medical Technology Co., Ltd. was founded in 2000. The company is mainly engaged in the research, development, manufacturing and sales of minimally invasive medical devices. Adhering to the purpose of "serving clinical practice with technology and innovation", we are committed to providing high-quality products and services to medical institutions around the world, helping all over the world improve medical level, reduce patient pain, and reduce medical costs. After nearly 20 years of innovative development, the company has gradually moved from a single non-vascular stent product to three major technology platforms, mainly from the domestic market to the domestic and international markets, and has become a high scientific research and innovation strength and core in the field of minimally invasive diagnosis and treatment. Product competitive advantage, industry leading company with rapid growth in performance. The company has undertaken three national scientific research projects, owned 36 domestic and foreign invention patents, obtained 28 registration certificates for Class III medical devices and 45 registration certificates for Class II medical devices. It has successively won the honorary titles of National Torch Program Key High-tech Enterprise, Jiangsu Province Science and Technology Small and Medium-sized Enterprise, Jiangsu Province Key R&D Institution, Jiangsu Province Private Science and Technology Enterprise, etc. The company's core products have competitive advantages. The company's main products include two main product series of endoscopic minimally invasive diagnostic and treatment devices and tumor ablation equipment. The company's newly developed endoscopic optical coherence tomography system (EOCT) has been obtained from the company's endoscopic minimally invasive diagnostic and treatment device product application. In the clinical diagnosis and treatment of digestive and respiratory diseases, it includes six sub-series of products, providing a systematic solution for endoscopic diagnosis and treatment. Among them, the technology that can carry 125I radiation therapy particle stent technology was rated as the world's first, and the main equipment for tumor ablation In order to perform precise microwave ablation of tumors, it has become one of the mainstream medical methods in the field of liver cancer treatment; EOCT is mainly used in conjunction with endoscopy and can be used for early cancer screening and surgical planning, and is expected to develop into the main means of "non-invasive optical biopsy". . The domestic and international markets drive the development of the company. In the domestic market, the company's endoscopic diagnosis and treatment technology products have played a strong role in import substitution, effectively reducing the cost of endoscopic diagnosis and treatment and reducing the burden on patients. The company's products have been sold to more than 2,900 hospitals across the country, and the coverage rate of Grade A hospitals has reached more than 55%. In terms of foreign markets, the company has subsidiaries in the United States and Germany, and its products have passed the approval of the US FDA and the EU CE certification. The products are exported to more than 70 countries and regions including developed countries such as the United States, Germany, Canada, and Japan. From 2016 to 2018, the company's sales revenue reached an average annual compound growth rate, with a growth rate far higher than the industry level. In order to maintain sustained growth, the company has strategically laid out its EOCT system with cutting-edge technical standards. It is the second product in the world to be approved by the US FDA. It is currently conducting clinical research in the Mayo Clinic, Stanford University Hospital Medical Center and other institutions in the United States. It is the company. An important growth point for future business development. In the future, the company will continue to focus on the core capability of transforming medical innovation achievements, continue to grow bigger and stronger, and enter the new minimally invasive diagnosis and treatment field in a timely manner in the future, striving to make the company a global leader in the minimally invasive diagnosis and treatment field.
Nanwei Medical Technology Co., Ltd.
Nanwei Medical Technology Co., Ltd. was founded in 2000. The company is mainly engaged in the research, development, manufacturing and sales of minimally invasive medical devices. Adhering to the purpose of "serving clinical practice with technology and innovation", we are committed to providing high-quality products and services to medical institutions around the world, helping all over the world improve medical level, reduce patient pain, and reduce medical costs. After nearly 20 years of innovative development, the company has gradually moved from a single non-vascular stent product to three major technology platforms, mainly from the domestic market to the domestic and international markets, and has become a high scientific research and innovation strength and core in the field of minimally invasive diagnosis and treatment. Product competitive advantage, industry leading company with rapid growth in performance. The company has undertaken three national scientific research projects, owned 36 domestic and foreign invention patents, obtained 28 registration certificates for Class III medical devices and 45 registration certificates for Class II medical devices. It has successively won the honorary titles of National Torch Program Key High-tech Enterprise, Jiangsu Province Science and Technology Small and Medium-sized Enterprise, Jiangsu Province Key R&D Institution, Jiangsu Province Private Science and Technology Enterprise, etc. The company's core products have competitive advantages. The company's main products include two main product series of endoscopic minimally invasive diagnostic and treatment devices and tumor ablation equipment. The company's newly developed endoscopic optical coherence tomography system (EOCT) has been obtained from the company's endoscopic minimally invasive diagnostic and treatment device product application. In the clinical diagnosis and treatment of digestive and respiratory diseases, it includes six sub-series of products, providing a systematic solution for endoscopic diagnosis and treatment. Among them, the technology that can carry 125I radiation therapy particle stent technology was rated as the world's first, and the main equipment for tumor ablation In order to perform precise microwave ablation of tumors, it has become one of the mainstream medical methods in the field of liver cancer treatment; EOCT is mainly used in conjunction with endoscopy and can be used for early cancer screening and surgical planning, and is expected to develop into the main means of "non-invasive optical biopsy". . The domestic and international markets drive the development of the company. In the domestic market, the company's endoscopic diagnosis and treatment technology products have played a strong role in import substitution, effectively reducing the cost of endoscopic diagnosis and treatment and reducing the burden on patients. The company's products have been sold to more than 2,900 hospitals across the country, and the coverage rate of Grade A hospitals has reached more than 55%. In terms of foreign markets, the company has subsidiaries in the United States and Germany, and its products have passed the approval of the US FDA and the EU CE certification. The products are exported to more than 70 countries and regions including developed countries such as the United States, Germany, Canada, and Japan. From 2016 to 2018, the company's sales revenue reached an average annual compound growth rate, with a growth rate far higher than the industry level. In order to maintain sustained growth, the company has strategically laid out its EOCT system with cutting-edge technical standards. It is the second product in the world to be approved by the US FDA. It is currently conducting clinical research in the Mayo Clinic, Stanford University Hospital Medical Center and other institutions in the United States. It is the company. An important growth point for future business development. In the future, the company will continue to focus on the core capability of transforming medical innovation achievements, continue to grow bigger and stronger, and enter the new minimally invasive diagnosis and treatment field in a timely manner in the future, striving to make the company a global leader in the minimally invasive diagnosis and treatment field.
Smith & Nephew Medical Products International Trade (Shanghai) Co., Ltd.
Smith+Nephew is a multinational medical device manufacturing company headquartered in London, UK. Founded in 1856, the company eliminates restrictions in life through design and production technology. It operates in more than 100 countries around the world and has more than 16,000 employees worldwide. Xerox is a member of the UK's FTSE100 and is listed on the London Stock Exchange and the New York Stock Exchange in the United States. Xerox's main businesses include orthopedics, sports medicine and ear, nose, throat (ENT) and advanced wound management products. In the orthopedic business, the company offers a range of hip and knee implants for replacing diseased, damaged or worn joints, robot-assisted empowerment technologies to enhance surgeons’ capabilities, and for severe fractures and correcting bone deformities. trauma products. In sports medicine and ENT businesses, the company provides advanced products and instruments for repairing or removing soft tissue. In addition, Xerox’s advanced wound management portfolio offers a comprehensive suite of solutions to meet a wide range of and complex clinical needs, committed to helping healthcare professionals keep moving closer to “zero” aspects of the human and economic impact of wounds. Target.
Smith & Nephew Medical Products International Trade (Shanghai) Co., Ltd.
Smith+Nephew is a multinational medical device manufacturing company headquartered in London, UK. Founded in 1856, the company eliminates restrictions in life through design and production technology. It operates in more than 100 countries around the world and has more than 16,000 employees worldwide. Xerox is a member of the UK's FTSE100 and is listed on the London Stock Exchange and the New York Stock Exchange in the United States. Xerox's main businesses include orthopedics, sports medicine and ear, nose, throat (ENT) and advanced wound management products. In the orthopedic business, the company offers a range of hip and knee implants for replacing diseased, damaged or worn joints, robot-assisted empowerment technologies to enhance surgeons’ capabilities, and for severe fractures and correcting bone deformities. trauma products. In sports medicine and ENT businesses, the company provides advanced products and instruments for repairing or removing soft tissue. In addition, Xerox’s advanced wound management portfolio offers a comprehensive suite of solutions to meet a wide range of and complex clinical needs, committed to helping healthcare professionals keep moving closer to “zero” aspects of the human and economic impact of wounds. Target.
Comerlin Fortec (Beijing) Medical Devices Co., Ltd.
Conmed is a global medical technology company that enables global healthcare providers to provide patients with good solutions through accessible Conmed solutions. For over 50 years, Conmed has provided innovations that impact results for healthcare professionals around the world. Dedicated to helping you improve your results with organic know-how and acquired brands and solutions. Conmed, which dates back to 1970, was founded by Eugene Corasanti in Utica, New York. It was originally called Consolidated Medical Equipment, Inc., focusing mainly on the production of disposable ECG monitoring electrodes. After decades of development, Conmed has become a giant with thousands of products serving the global healthcare field. Conmed's product line covers a variety of specialized areas, including orthopedic surgery, laparoscopy, robotics and open surgery, gastroenterology and pulmonary arts, patient care, and more. Among them, minimally invasive technologies and products in the fields of orthopedics and surgery are particularly prominent, including orthopedic sports medicine solutions, power tool systems, high-frequency electrocution energy systems, 3D and 2D endoscopic systems, and intelligent pneumoresis machine systems. These products are widely used in orthopedics, general surgery, urology, obstetrics and gynecology and other fields, providing strong technical support to doctors. In addition to the richness of the product, Conmed also focuses on R&D and innovation. The company has multiple manufacturing and design facilities, as well as more than 3500 employees, who are committed to designing, producing and marketing innovative high-quality products to improve the quality of healthcare. This persistence in innovation has enabled Conmed to maintain a leading position in the field of medical technology. In addition, Conmed is actively seeking cooperation and acquisitions with other medical technology companies to expand its business scope and enhance its market position. For example, Conmed has acquired In2Bones Global, a company focusing on the development and sale of medical devices for upper and lower limb diseases and injuries. The acquisition further strengthens Conmed's strength in the field of medical technology.
Comerlin Fortec (Beijing) Medical Devices Co., Ltd.
Conmed is a global medical technology company that enables global healthcare providers to provide patients with good solutions through accessible Conmed solutions. For over 50 years, Conmed has provided innovations that impact results for healthcare professionals around the world. Dedicated to helping you improve your results with organic know-how and acquired brands and solutions. Conmed, which dates back to 1970, was founded by Eugene Corasanti in Utica, New York. It was originally called Consolidated Medical Equipment, Inc., focusing mainly on the production of disposable ECG monitoring electrodes. After decades of development, Conmed has become a giant with thousands of products serving the global healthcare field. Conmed's product line covers a variety of specialized areas, including orthopedic surgery, laparoscopy, robotics and open surgery, gastroenterology and pulmonary arts, patient care, and more. Among them, minimally invasive technologies and products in the fields of orthopedics and surgery are particularly prominent, including orthopedic sports medicine solutions, power tool systems, high-frequency electrocution energy systems, 3D and 2D endoscopic systems, and intelligent pneumoresis machine systems. These products are widely used in orthopedics, general surgery, urology, obstetrics and gynecology and other fields, providing strong technical support to doctors. In addition to the richness of the product, Conmed also focuses on R&D and innovation. The company has multiple manufacturing and design facilities, as well as more than 3500 employees, who are committed to designing, producing and marketing innovative high-quality products to improve the quality of healthcare. This persistence in innovation has enabled Conmed to maintain a leading position in the field of medical technology. In addition, Conmed is actively seeking cooperation and acquisitions with other medical technology companies to expand its business scope and enhance its market position. For example, Conmed has acquired In2Bones Global, a company focusing on the development and sale of medical devices for upper and lower limb diseases and injuries. The acquisition further strengthens Conmed's strength in the field of medical technology.
NewOptic Medical Technology (Suzhou) Co., Ltd.
Founded in October 2016, Xinguangwei Medical is a minimally invasive diagnosis and treatment enterprise focusing on the research and development and commercialization of medical endoscopes and related innovative products. "Based in China and looking at the world", the company's headquarters and R&D base are located in Suzhou Industrial Park, and have established subsidiaries and branches in Tokyo, Shanghai, Chengdu, Nanjing and other places in Japan. Relying on its strong self-development capabilities and unique core technology platform, Xinguangwei Medical has created an innovative and high-quality "reusable endoscope + disposable endoscope + supporting consumables" complete set of minimally invasive diagnosis and treatment solutions under the endoscope, products It covers multiple clinical departments such as general surgery, gynecology, hepatobiliary surgery, urology and respiratory intervention, and has been sold to many countries and regions around the world. Adhering to the corporate values of "focusing on clinical practice", "collaborative innovation", "people-oriented" and "excellent and efficient", Xinguangwei Medical will continue to upgrade its core technology of minimally invasive diagnosis and treatment, and increase market penetration through excellent product strength, becoming the primary trust of doctors and patients around the world. Choose a brand.
NewOptic Medical Technology (Suzhou) Co., Ltd.
Founded in October 2016, Xinguangwei Medical is a minimally invasive diagnosis and treatment enterprise focusing on the research and development and commercialization of medical endoscopes and related innovative products. "Based in China and looking at the world", the company's headquarters and R&D base are located in Suzhou Industrial Park, and have established subsidiaries and branches in Tokyo, Shanghai, Chengdu, Nanjing and other places in Japan. Relying on its strong self-development capabilities and unique core technology platform, Xinguangwei Medical has created an innovative and high-quality "reusable endoscope + disposable endoscope + supporting consumables" complete set of minimally invasive diagnosis and treatment solutions under the endoscope, products It covers multiple clinical departments such as general surgery, gynecology, hepatobiliary surgery, urology and respiratory intervention, and has been sold to many countries and regions around the world. Adhering to the corporate values of "focusing on clinical practice", "collaborative innovation", "people-oriented" and "excellent and efficient", Xinguangwei Medical will continue to upgrade its core technology of minimally invasive diagnosis and treatment, and increase market penetration through excellent product strength, becoming the primary trust of doctors and patients around the world. Choose a brand.
Zhejiang Huanuokang Technology Co., Ltd.
Zhejiang Huanuokang Technology Co., Ltd. is a high-tech company focusing on the research and development, production, sales and services of high-end medical devices. It is a world-class digital medical care jointly invested by Zhejiang Dahua Technology Co., Ltd. and its founder Mr. Fu Liquan. Solution provider. Vanuakon Technology has brought together a team of experts from the integration of products, hardware, software and algorithms to achieve world priority in embedded system development, image and video processing, intelligent algorithms, etc. Based on the global outlets, it is based on its forward-looking and innovative self-development, providing customers with high-quality products and ultimate services, and continuously creating value for customers. Adhering to the strategy of combining "production", "learning" and "research", Vanuakang Technology has carried out in-depth cooperation with major universities and Grade A hospitals. It will give priority to image technology and years of rich experience in clinical practice to provide medical industry. Provide international and high-level medical solutions that "beyond your horizons and break through expectations".
Zhejiang Huanuokang Technology Co., Ltd.
Zhejiang Huanuokang Technology Co., Ltd. is a high-tech company focusing on the research and development, production, sales and services of high-end medical devices. It is a world-class digital medical care jointly invested by Zhejiang Dahua Technology Co., Ltd. and its founder Mr. Fu Liquan. Solution provider. Vanuakon Technology has brought together a team of experts from the integration of products, hardware, software and algorithms to achieve world priority in embedded system development, image and video processing, intelligent algorithms, etc. Based on the global outlets, it is based on its forward-looking and innovative self-development, providing customers with high-quality products and ultimate services, and continuously creating value for customers. Adhering to the strategy of combining "production", "learning" and "research", Vanuakang Technology has carried out in-depth cooperation with major universities and Grade A hospitals. It will give priority to image technology and years of rich experience in clinical practice to provide medical industry. Provide international and high-level medical solutions that "beyond your horizons and break through expectations".
Pentax Medical (Shanghai) Co., Ltd.
PENTAXMedical is a branch of the HOYA Group that provides endoscopic imaging solutions and is a diversified multinational company with research and development innovation and manufacturing centers in Japan, Europe and the United States. Pentax Medical was founded in Japan in 1919 and was originally named Asahi Optical Co., Ltd. In 1970, Pentax Medical was listed on the Tokyo Stock Exchange. In 1977, he started to open branches in Europe and the United States, and since then he embarked on the path of globalization. In 2005, Pentax, the United States acquired Kay Elemetrics. 2008 HOYACorporation acquired PENTAX. In 2011, HOYA split the Pentax digital cameras, telescopes and other businesses to Ricoh RICHO, retaining core businesses such as endoscopes and artificial bones. Both parties share the Pentax trademark. In 2011, Pentax Medical (Shanghai) Co., Ltd. was established to set up its layout in Asia. In 2012, HOYA acquired Digital Endoscopy GmbH, a digital endoscope company. In 2013, HOYA Heuer Group and Wassenburg Medical Devices established a joint venture in the field of endoscopy. In 2015, Pentax Medical invested in Creo Medical Co., Ltd. In 2017, Pentax Medical acquired C2Therapeutics, which owns CryoBalloon ablation technology for the treatment of Barrett's esophageal and squamous dysplasia.
Pentax Medical (Shanghai) Co., Ltd.
PENTAXMedical is a branch of the HOYA Group that provides endoscopic imaging solutions and is a diversified multinational company with research and development innovation and manufacturing centers in Japan, Europe and the United States. Pentax Medical was founded in Japan in 1919 and was originally named Asahi Optical Co., Ltd. In 1970, Pentax Medical was listed on the Tokyo Stock Exchange. In 1977, he started to open branches in Europe and the United States, and since then he embarked on the path of globalization. In 2005, Pentax, the United States acquired Kay Elemetrics. 2008 HOYACorporation acquired PENTAX. In 2011, HOYA split the Pentax digital cameras, telescopes and other businesses to Ricoh RICHO, retaining core businesses such as endoscopes and artificial bones. Both parties share the Pentax trademark. In 2011, Pentax Medical (Shanghai) Co., Ltd. was established to set up its layout in Asia. In 2012, HOYA acquired Digital Endoscopy GmbH, a digital endoscope company. In 2013, HOYA Heuer Group and Wassenburg Medical Devices established a joint venture in the field of endoscopy. In 2015, Pentax Medical invested in Creo Medical Co., Ltd. In 2017, Pentax Medical acquired C2Therapeutics, which owns CryoBalloon ablation technology for the treatment of Barrett's esophageal and squamous dysplasia.
Shenzhen Zifu Medical Technology Co., Ltd.
Shenzhen Zifu Medical Technology Co., Ltd. was founded in 2011. It is a national high-tech enterprise focusing on the research, development, production, sales and service of gastrointestinal medical products. The company is headquartered in the High-tech Industrial Park, Nanshan District, Shenzhen, and has set up a modern production base in Shenzhen Guangming. The company has established a medical device quality management system, passed the medical device production quality management specification (GMP) inspection and ISO13485 quality management system certification. The company has built a professional R&D team and an international R&D management platform, and has undertaken a number of technological innovation projects in the country and Shenzhen, and has obtained more than 100 national patents. The "Da Sheng" magnetron capsule endoscope system series products that adhere to independent innovation and uphold the spirit of craftsmanship have been independently developed for ten years. They have obtained the NMPA Class III medical device registration and EU CE certification (EC certification) of the National Medical Products Administration. , widely praised by medical institutions. The company has always adhered to the quality policy of "using professional technology, scientific processes, research and development of innovative products, and providing customers with safe and effective medical and health products and services". It is determined to become a respected century-old medical enterprise and continue to serve human beings. Contribute to the health cause.
Shenzhen Zifu Medical Technology Co., Ltd.
Shenzhen Zifu Medical Technology Co., Ltd. was founded in 2011. It is a national high-tech enterprise focusing on the research, development, production, sales and service of gastrointestinal medical products. The company is headquartered in the High-tech Industrial Park, Nanshan District, Shenzhen, and has set up a modern production base in Shenzhen Guangming. The company has established a medical device quality management system, passed the medical device production quality management specification (GMP) inspection and ISO13485 quality management system certification. The company has built a professional R&D team and an international R&D management platform, and has undertaken a number of technological innovation projects in the country and Shenzhen, and has obtained more than 100 national patents. The "Da Sheng" magnetron capsule endoscope system series products that adhere to independent innovation and uphold the spirit of craftsmanship have been independently developed for ten years. They have obtained the NMPA Class III medical device registration and EU CE certification (EC certification) of the National Medical Products Administration. , widely praised by medical institutions. The company has always adhered to the quality policy of "using professional technology, scientific processes, research and development of innovative products, and providing customers with safe and effective medical and health products and services". It is determined to become a respected century-old medical enterprise and continue to serve human beings. Contribute to the health cause.
Chongqing Jinshan Science & Technology Group Co., Ltd.
Chongqing Jinshan Technology Group Co., Ltd. was established in 1998. It is a national high-tech enterprise integrating the research and development, production, sales and service of digital medical equipment. The company has established the "Academician Workstation" and "Doctoral Workstation" with the micro system MEMS technology as the core, and has received support from many experts. It has successively undertaken dozens of national-level "863 Plan", national science and technology research plan, international cooperation plan and other national-level cooperation plan. The scientific research plan has dozens of medical device products, including capsule endoscopy, pH capsule, esophageal impedance-pH joint monitoring system, uterine cavity observation and attraction surgery system (gynecology), impedance CT, etc. The company's products and solutions have been widely used in more than 80 countries and regions including Spain, Italy, the United Kingdom, Germany, Russia, Canada, India, etc. The company takes it as its mission to protect people's health, insists on independent innovation, and continues to develop "minimally invasive, disposable, intelligent, integrated and networked" high-tech medical devices, in medical imaging, biochemical testing, active implantable interventional devices, and remote Research has been carried out extensively in the fields of medical information management.
Chongqing Jinshan Science & Technology Group Co., Ltd.
Chongqing Jinshan Technology Group Co., Ltd. was established in 1998. It is a national high-tech enterprise integrating the research and development, production, sales and service of digital medical equipment. The company has established the "Academician Workstation" and "Doctoral Workstation" with the micro system MEMS technology as the core, and has received support from many experts. It has successively undertaken dozens of national-level "863 Plan", national science and technology research plan, international cooperation plan and other national-level cooperation plan. The scientific research plan has dozens of medical device products, including capsule endoscopy, pH capsule, esophageal impedance-pH joint monitoring system, uterine cavity observation and attraction surgery system (gynecology), impedance CT, etc. The company's products and solutions have been widely used in more than 80 countries and regions including Spain, Italy, the United Kingdom, Germany, Russia, Canada, India, etc. The company takes it as its mission to protect people's health, insists on independent innovation, and continues to develop "minimally invasive, disposable, intelligent, integrated and networked" high-tech medical devices, in medical imaging, biochemical testing, active implantable interventional devices, and remote Research has been carried out extensively in the fields of medical information management.
Wolf Medical Device Trading (Taicang) Co., Ltd.
Richard Wolf Germany Co., Ltd. offers a variety of products and systems for endoscopy and external shock wave therapy. The equipment provided by the company involves almost all specialized disciplines in human medicine. As an auxiliary, the product series is also equipped with an operating room management system called core nova. The core nova system can relieve the burden of operating room staff from performing organizational management, making the system equally suitable for hospitals and medical clinics. Industrial endoscopes make existing equipment products more perfect.
Wolf Medical Device Trading (Taicang) Co., Ltd.
Richard Wolf Germany Co., Ltd. offers a variety of products and systems for endoscopy and external shock wave therapy. The equipment provided by the company involves almost all specialized disciplines in human medicine. As an auxiliary, the product series is also equipped with an operating room management system called core nova. The core nova system can relieve the burden of operating room staff from performing organizational management, making the system equally suitable for hospitals and medical clinics. Industrial endoscopes make existing equipment products more perfect.
Teleflex Medical Device Trading (Shanghai) Co., Ltd.
Teleflex is a global provider of medical technology dedicated to improving people's health and quality of life. Using a goal-driven innovation approach, Teleflex continues to explore unmet clinical needs, providing support to healthcare professionals who are constantly working to create a healthy future. Teleflex’s portfolio offers solutions in vascular access and interventional therapy, surgery, anesthesia, cardiac care, urinary, acute medicine and respiratory care. More than 14,000 Teleflex employees around the world are united and united, believing that what they do every day is of great significance. Teleflex’s brands include Arrow®, Deknatel®, LMA®, Pilling®, QuikClot®, Rüsch®, UroLift® and Weck®.
Teleflex Medical Device Trading (Shanghai) Co., Ltd.
Teleflex is a global provider of medical technology dedicated to improving people's health and quality of life. Using a goal-driven innovation approach, Teleflex continues to explore unmet clinical needs, providing support to healthcare professionals who are constantly working to create a healthy future. Teleflex’s portfolio offers solutions in vascular access and interventional therapy, surgery, anesthesia, cardiac care, urinary, acute medicine and respiratory care. More than 14,000 Teleflex employees around the world are united and united, believing that what they do every day is of great significance. Teleflex’s brands include Arrow®, Deknatel®, LMA®, Pilling®, QuikClot®, Rüsch®, UroLift® and Weck®.
PENTAX Europe provides advanced endoscopic imaging solutions for medical professionals. The company is known for its innovative products that enhance diagnostic and therapeutic procedures.
HOYA Corporation
PENTAX Europe provides advanced endoscopic imaging solutions for medical professionals. The company is known for its innovative products that enhance diagnostic and therapeutic procedures.
Medtronic (Shanghai) Management Co., Ltd.
Because of extraordinary technology, life is facing severe health challenges, Medtronic uses advanced medical technology to bring extraordinary life experience to patients and inspire hope and possibilities in people's lives. Every day, many people face severe health challenges, but ordinary life is a luxury for them. When a type I diabetic patient went out to a friend's house, his father often worried about his son's blood sugar soaring; a woman with an arrhythmia was worried all day long. Some things that seem natural to ordinary people are troubled and struggled by. As a global medical technology company, Medtronic has expectations and strives to achieve more possibilities through innovation and its own profession, bringing patients an extraordinary life experience. Medtronic is committed to solving the complex challenges facing today's healthcare systems, and its business has expanded to more than 70 key disease areas. Medtronic acts quickly and seizes the day to serve more patients around the world with medical technology. Introduce data, artificial intelligence, automation technologies based on patient needs – turning insights into actions to make continuous improvements to the healthcare system. We hope to use technology to ignite the hope of life for patients and bring new possibilities. Medtronic operates in more than 150 countries and regions and has more than 90,000 employees worldwide. We expand access and strive to create more positive impacts beyond our own products. We are committed to promoting inclusion, diversity and equity, and we are committed to protecting our planet to create better results for all.
Medtronic (Shanghai) Management Co., Ltd.
Because of extraordinary technology, life is facing severe health challenges, Medtronic uses advanced medical technology to bring extraordinary life experience to patients and inspire hope and possibilities in people's lives. Every day, many people face severe health challenges, but ordinary life is a luxury for them. When a type I diabetic patient went out to a friend's house, his father often worried about his son's blood sugar soaring; a woman with an arrhythmia was worried all day long. Some things that seem natural to ordinary people are troubled and struggled by. As a global medical technology company, Medtronic has expectations and strives to achieve more possibilities through innovation and its own profession, bringing patients an extraordinary life experience. Medtronic is committed to solving the complex challenges facing today's healthcare systems, and its business has expanded to more than 70 key disease areas. Medtronic acts quickly and seizes the day to serve more patients around the world with medical technology. Introduce data, artificial intelligence, automation technologies based on patient needs – turning insights into actions to make continuous improvements to the healthcare system. We hope to use technology to ignite the hope of life for patients and bring new possibilities. Medtronic operates in more than 150 countries and regions and has more than 90,000 employees worldwide. We expand access and strive to create more positive impacts beyond our own products. We are committed to promoting inclusion, diversity and equity, and we are committed to protecting our planet to create better results for all.
